The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global drug-coated balloons market is on an upward trajectory, set to grow from $0.82 billion in 2022 to $0.95 billion in 2023, boasting a substantial compound annual growth rate (CAGR) of 13.2%. Looking ahead, the market is anticipated to reach $1.69 billion in 2027, maintaining a robust CAGR of 15.4%. What catalyzes this remarkable ascent?

1. The Surge in Coronary Artery Disease Cases
   Propelling the Need for Innovative Solutions
   A primary catalyst driving the drug-coated balloons market is the rise in the prevalence of coronary artery disease (CAD). This medical condition, characterized by the narrowing or obstruction of the coronary arteries, poses a significant health threat, often leading to heart attacks. Drug-coated balloons, a cutting-edge medical device, play a pivotal role in treating CAD. The drug released during the procedure helps prevent restenosis, the re-narrowing of the artery after angioplasty.

• Example: According to the Centers for Disease Control and Prevention, the percentage of coronary heart disease for adults in the United States increased from 4.6% in 2020 to 4.9% in 2021, underscoring the escalating prevalence of CAD.

2. Key Players Shaping the Landscape
   Navigating the Market Dynamics
   Major players wield significant influence in the drug-coated balloons market, contributing to its growth and innovation. Acotec Scientific AG, Becton Dickinson and Company, and Medtronic PLC are among the key players driving advancements, fostering innovation, and addressing the evolving needs in cardiac care.

Innovation Takes Center Stage
A Key Trend in Drug-Coated Balloon Development
A pivotal trend gaining traction in the drug-coated balloons market is a relentless focus on product innovation. Leading companies are actively developing technological solutions to strengthen their positions in the market and enhance the efficacy of drug-coated balloon procedures.

• Example: In November 2020, Boston Scientific Corporation received FDA approval for the Ranger Drug-Coated Balloon, designed to treat patients with peripheral arterial disease. The Ranger DCB, with its low therapeutic drug dose and unique coating, ensures high primary patency rates and minimizes systemic drug exposure for patients.

Market Segmentation: A Comprehensive Approach
Understanding the Diversity
The drug-coated balloons market boasts a comprehensive segmentation, reflecting the diversity of products and applications within the industry.

1. By Product

• Drug-Coated Balloons For Peripheral Artery Disease
• Drug-Coated Balloons For Coronary Artery Disease
• Drug-Coated Balloons For Other Indications

2. By Drug Type

• Paclitaxel
• Sirolimus

3. By End User

• Hospitals
• Cardiac Catheterization Labs
• Ambulatory Surgical Centers

Regional Dynamics: North America Leading the Charge
2022 Market Prowess and Future Growth
As of 2022, North America emerges as the dominant force in the global drug-coated balloons market. With a significant market share, this region not only influences current trends but plays a pivotal role in shaping the future trajectory of the industry. Additionally, North America is expected to be the fastest-growing region in the forecast period, highlighting its pivotal role in advancing cardiac care.

View More On The Drug-Coated Balloons Market Report 2023 – https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

Request A Sample Of The Global Drug-Coated Balloons Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=10829&type=smp

The Drug-Coated Balloons Global Market Report 2023offers a comprehensive overview on the drug-coated balloons market size, growth rate, trends and drivers, opportunities, strategies, and competitor landscape. The countries covered in the drug-coated balloons market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The Table Of Content For The Drug-Coated Balloons Market Include:
1. Drug-Coated Balloons Market Executive Summary
2. Drug-Coated Balloons Market Segments
3. Drug-Coated Balloons Market Size And Drug-Coated Balloons Market Growth Rate
4. Key Drug-Coated Balloons Market Trends
5. Major Drug-Coated Balloons Market Drivers
……
25. Key Mergers And Acquisitions In The Drug-Coated Balloons Market
26. Top Drug-Coated Balloons Companies
27. Drug-Coated Balloons Market Opportunities And Strategies
28. Drug-Coated Balloons Market, Conclusions And Recommendations
29. Appendix

View More Related Reports –
PTA Balloon Catheter Global Market Report 2023
Pain Management Drugs Global Market Report 2023
Small Molecule Drug Discovery Global Market Report 2023

Contact us at:
The Business Research Company:https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn:https://in.linkedin.com/company/the-business-research-company
YouTube:https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model:https://www.thebusinessresearchcompany.com/global-market-model